MTOR and von Hippel-Lindau disease: Unlike other hereditary syndromes, such as von Hippel–Lindau disease (VHL) and hereditary leiomyomatosis and renal cell carcinoma (HLRCC), histologic manifestations of renal tumors associated with TSC/mTOR pathway alterations are heterogenous.